Calliditas Year-end report, January - December 2023 : vimars

/PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq Stockholm: CALTX) 2023: Full approval for TARPEYO in the US; a year of successes OCTOBER – DECEMBER 2023...

Related Keywords

United States , China , Stockholm , Sweden , , Drug Administration , China National Medical Products Administration , European Commission , Nasdaq Stockholm , Everest Medicines , National Medical Products Administration , Nefecon Open , Marketing Authorization Holder , Calliditas Therapeutics , Biotechnology , Computer Amp Electronics , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Earnings , Accounting News Amp Issues ,